Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Liao PF, Wang PY, Peng TR

Open source

DOI
10.3390/curroncol30110722
Published
2023 Nov 17
Container
Current oncology (Toronto, Ont.)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol30110722,
  title = {Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.},
  author = {Liao PF and Wang PY and Peng TR},
  year = {2023},
  journal = {Current oncology (Toronto, Ont.)},
  doi = {10.3390/curroncol30110722},
  url = {https://doi.org/10.3390/curroncol30110722}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
AU  - Liao PF
AU  - Wang PY
AU  - Peng TR
PY  - 2023
JO  - Current oncology (Toronto, Ont.)
DO  - 10.3390/curroncol30110722
UR  - https://doi.org/10.3390/curroncol30110722
ER  - 

APA

PF, L., PY, W., & TR, P. (2023). Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol30110722

Source records